There have been 22 recent insider transactions recorded for LAVA Therapeutics N.V. (LVTX), including 10 buys and 0 sells. Total insider buying was valued at $766.67K and total insider selling at RSU Award.
Notable insiders with recent activity include Hurly Stephen A, Wilson Karen J, Kiener Peter A. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — LVTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-02-13 |
Hurly Stephen A |
Chief Executive Officer |
RSU Award |
335,100 |
$0.93 |
$311.64K |
335,100 |
| 2025-02-13 |
Wilson Karen J |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Kiener Peter A |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Powell Fred M |
Chief Financial Officer |
RSU Award |
124,700 |
$0.93 |
$115.97K |
124,700 |
| 2025-02-13 |
Noble James |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Dhingra Kapil |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Morris Charles Q |
Chief Medical Officer |
RSU Award |
130,850 |
$0.93 |
$121.69K |
130,850 |
| 2025-02-13 |
Backstrom Jay T. |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Wadlinger Mary E. |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-02-13 |
Oliger Christy J. |
Director |
RSU Award |
33,390 |
$0.93 |
$31.05K |
33,390 |
| 2025-01-01 |
Hurly Stephen A |
Chief Executive Officer |
Unknown |
310,210 |
$1.59 |
$493.23K |
- |
| 2025-01-01 |
Wilson Karen J |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Kiener Peter A |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Powell Fred M |
Chief Financial Officer |
Unknown |
120,950 |
$1.59 |
$192.31K |
- |
| 2025-01-01 |
Noble James |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Dhingra Kapil |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Morris Charles Q |
Chief Medical Officer |
Unknown |
160,400 |
$1.59 |
$255.04K |
- |
| 2025-01-01 |
Backstrom Jay T. |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Wadlinger Mary E. |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Oliger Christy J. |
Director |
Unknown |
33,390 |
$1.59 |
$53.09K |
- |
| 2025-01-01 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Unknown |
- |
- |
- |
1,180,680 |
| 2025-01-01 |
Cooperatieve Gilde Healthcare Iv U.a. |
10 Percent Owner |
Unknown |
- |
- |
- |
5,421,170 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
